Details checkedClinical trial listing onlyHistorical/discontinuedCheckedregistry

Hormone replacement therapy auditory-aging exposure study

Also known as: Hormone Replacement Therapy - HRT, HRT auditory aging study

Institution-led study

Primary source

Sponsor / Institution

Institution-led study

Program Type

Therapeutic

Modality

Small Molecule

Stage

Not applicable

Status

Completed

Target Gene

—

Route / Mode

Observational exposure

Confidence

84%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-10

Geography

United States

Population

adult, older-adult, age-related

Trial IDs

Mechanism

Observational age-related hearing study that captured hormone replacement therapy exposure while evaluating neural and psychoacoustic changes in the aging auditory system.

Indications

Hearing Loss Age-Related Hearing Loss

Notes

Registry-verified observational auditory-aging study. HRT should be interpreted as an exposure/intervention field in the registry, not as a company-sponsored hearing-loss drug program.

Evidence & Sources

1 structured sources

clinicaltrials

Supports: canonicalName, company, allCompanies, isIndustrySponsored, programType, modality, mechanism, indications...

IDs: NCT00264407

Open

Key Events

2001-01

2005-02

Study completed

Clinical Trials (1)

NCT00264407